IOP Medical

Company Overview

Snapshot

Founded in June 2016 by Prof. Yossi Mandel, IOP Medical operates with 1–10 employees. The company has secured funding from 2 investors across one funding round, with G.O Innovation and Stanford University participating. IOP Medical is developing an implantable sensor for self-monitoring of intraocular pressure, leveraging technology patented at Stanford University.

Business overview

IOP Medical is an ophthalmology startup focused on developing an implantable sensor for self-monitoring of intraocular pressure. The core technology, developed and patented at Stanford University, enables users to monitor their intraocular pressure using a simple smartphone camera. The company operates within the Health Tech & Life Sciences sector, specifically targeting digital healthcare and medical devices for chronic patients, particularly those with glaucoma, and serves global markets.

Company Intelligence Q&A

What is IOP Medical's core technology?

IOP Medical is developing an implantable sensor for self-monitoring of intraocular pressure. This technology, which is based on intellectual property developed and patented at Stanford University, allows for monitoring using a smartphone camera.

Who founded IOP Medical?

IOP Medical was founded by Prof. Yossi Mandel, who also serves as the company's Chief Scientist and Inventor.

Which investors participated in IOP Medical's funding round?

In January 2019, IOP Medical received funding from G.O Innovation and Stanford University.

What is IOP Medical's primary focus in the healthcare sector?

IOP Medical focuses on ophthalmology, specifically addressing the need for remote monitoring solutions for conditions like glaucoma through its implantable sensor technology.

What is the current product development stage for IOP Medical?

IOP Medical's product is currently in the R&D stage, focusing on developing its implantable sensor technology.